Clinical Trial Update: Study of FYU-981 in Hyperuricemia With or Without Gout [Phase 3]

View source ↗

Summary

Phase 3 trial update for FYU-981 in hyperuricemia with or without gout has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia with Gout

Drugs mentioned

• FYU-981

Snippet

Sponsor: Fuji Yakuhin Co., Ltd. | Conditions: Hyperuricemia With or Without Gout | Phase 3 | Status: COMPLETED